Dr Reddys Laboratories (RDY) Exchange Rate Effect (2009)
Dr Reddys Laboratories (RDY) posted quarterly Exchange Rate Effect of $16.0 million for Q4 2009, up 206.67% quarter-over-quarter from -$15.0 million in Q3 2009.
Dr Reddys Laboratories (RDY) Exchange Rate Effect (2009) Analysis & Trends
Dr Reddys Laboratories' Exchange Rate Effect history runs 1 years deep, the most recent figure standing at $16.0 million for Q4 2009.
- In Q4 2009, Exchange Rate Effect changed N/A year-over-year to $16.0 million; the TTM figure through Dec 2009 stood at -$1.4 million (changed N/A YoY), while the FY2026 annual figure was $13.0 million, up 1200.0% from the prior year.
- Exchange Rate Effect for Q4 2009 stood at $16.0 million, up from -$15.0 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $16.0 million in Q4 2009, with the low at -$15.0 million in Q3 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2009 | 16.00 Mn |
| Dec 31, 2009 | 16.00 Mn |
| Sep 30, 2009 | -15.00 Mn |
| Sep 30, 2009 | -15.00 Mn |
| Jun 30, 2009 | 6.00 Mn |
| Jun 30, 2009 | 6.00 Mn |